News
Equifax faces growth headwinds, premium valuation, and flat price action despite AI and cloud investments, with limited ...
I am reversing my rating on Akero Therapeutics stock from Buy to Sell due to valuation concerns and a long-ish wait for ...
2d
TipRanks on MSNAkero Therapeutics’ efruxifermin shows efficacy in Phase 2b MASH, fibrosis trial
Akero Therapeutics (AKRO) announced publication of 96-week final results from the Phase 2b HARMONY trial in The Lancet in adults with ...
12d
Zacks Investment Research on MSNCRAI vs. EFX: Which Stock Is the Better Value Option?
Let's take a closer look.Everyone has their own methods for finding great value opportunities, but our model includes pairing an impressive grade in the Value category of our Style Scores system with ...
In recent trading, shares of Equifax Inc (Symbol: EFX) have crossed above the average analyst 12-month target price of $205.75, changing hands for $209.53/share. When a stock reaches the target an ...
By comparison, EFX has a P/B of 7.98. These metrics, and several others, help EVTC earn a Value grade of B, while EFX has been given a Value grade of D.
Efx Fragments is available now at an introductory price of $99, though if you already own other Arturia products there's probably a steep discount waiting for you.
Phantom EFX, a leading developer and publisher of PC-based casino and card game titles, today announced Reel Deal Slots: Adventure III "World Tour", the latest installment in its popular and genre ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results